Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12257)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2014 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, Cruceru ML, Albulescu R. Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics. World J Gastroenterol 2014; 20(31): 10790-10801 [PMID: 25152582 DOI: 10.3748/wjg.v20.i31.10790] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i31/10790.htm |
| Number | Citing Articles |
| 1 |
Mohamed J. Saadh, Hala Baher, Yuanji Li, Mvnl chaitanya, José Luis Arias-Gonzáles, Omer Qutaiba B. Allela, Mohammed H. Mahdi, Juan Carlos Cotrina-Aliaga, Natrayan Lakshmaiya, Salam Ahjel, Ali H. Amin, Gregorio Gilmer Rosales Rojas, Fuad Ameen, Muhammad Ahsan, Reza Akhavan-Sigari. The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery. Environmental Research 2023; 233: 116490 doi: 10.1016/j.envres.2023.116490
|
| 2 |
Yan-Bo Zheng, Meng-Ran Zhang, Yi Li, Xiu-Jun Liu, Yong-Su Zhen. DBDx-based drug combinations show highly potent therapeutic efficacy against human pancreatic cancer xenografts in athymic mice. Cancer Biology & Therapy 2020; 21(8): 749 doi: 10.1080/15384047.2020.1776580
|
| 3 |
Esther Pilar García-Santos, David Padilla-Valverde, Pedro Villarejo-Campos, Cristina Murillo-Lázaro, Esther Fernández-Grande, Teodoro Palomino-Muñoz, Marta Rodríguez-Martínez, Mariano Amo-Salas, Paloma Nuñez-Guerrero, Susana Sánchez-García, Alejandro Puerto-Puerto, Jesús Martín-Fernández. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4+. Pancreatology 2016; 16(4): 632 doi: 10.1016/j.pan.2016.04.031
|
| 4 |
Haiyong Wang, Zhouyu Ning, Yingyi Li, Xiaoyan Zhu, Zhiqiang Meng. Bufalin suppresses cancer stem-like cells in gemcitabine-resistant pancreatic cancer cells via Hedgehog signaling. Molecular Medicine Reports 2016; 14(3): 1907 doi: 10.3892/mmr.2016.5471
|
| 5 |
Aoife S Crawley, Richard J O’Kennedy. The need for effective pancreatic cancer detection and management: a biomarker-based strategy. Expert Review of Molecular Diagnostics 2015; 15(10): 1339 doi: 10.1586/14737159.2015.1083862
|
| 6 |
Elena Montano, Alessandra Pollice, Valeria Lucci, Geppino Falco, Ornella Affinito, Girolama La Mantia, Maria Vivo, Tiziana Angrisano. Pancreatic Progenitor Commitment Is Marked by an Increase in Ink4a/Arf Expression. Biomolecules 2021; 11(8): 1124 doi: 10.3390/biom11081124
|
| 7 |
Joo Kyung Park, Yejin Kim, Hyemin Kim, Jane Jeon, Tae Wan Kim, Ji-Hong Park, Young-il Hwnag, Wang Jae Lee, Jae Seung Kang. The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma. Oncotarget 2016; 7(46): 75081 doi: 10.18632/oncotarget.12057
|
| 8 |
Cristiana Tanase, Ancuta-Augustina Gheorghisan-Galateanu, Ionela Daniela Popescu, Simona Mihai, Elena Codrici, Radu Albulescu, Mihail Eugen Hinescu. CD36 and CD97 in Pancreatic Cancer versus Other Malignancies. International Journal of Molecular Sciences 2020; 21(16): 5656 doi: 10.3390/ijms21165656
|
| 9 |
T.Y.S. Le Large, M.F. Bijlsma, G. Kazemier, H.W.M. van Laarhoven, E. Giovannetti, C.R. Jimenez. Key biological processes driving metastatic spread of pancreatic cancer as identified by multi-omics studies. Seminars in Cancer Biology 2017; 44: 153 doi: 10.1016/j.semcancer.2017.03.008
|
| 10 |
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. International Journal of Molecular Sciences 2019; 20(17): 4154 doi: 10.3390/ijms20174154
|
| 11 |
Maurizio Romano, Francesco De Francesco, Enrico Gringeri, Antonio Giordano, Giuseppe A. Ferraro, Marina Di Domenico, Umberto Cillo. Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?. Journal of Cellular Physiology 2016; 231(4): 768 doi: 10.1002/jcp.25190
|
| 12 |
Jeyameenakshi Annamalai, Harini Kasilingam. BIO-PROSPECTING FOR ACTIVE COMPOUNDS: FTIR AND GCMS PROFILING OF ETHYL ACETATE-EXTRACTED SECONDARY METABOLITES FROM SEA WATER-ORIGIN ACINETOBACTER BAUMANNII MP-1. INDIAN DRUGS 2024; 61(07): 59 doi: 10.53879/id.61.07.14630
|
| 13 |
Caixia Liang, Tomohiko Fukuda, Tomoya Isaji, Chengwei Duan, Wanli Song, Yuqin Wang, Jianguo Gu. α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma. Biochimica et Biophysica Acta (BBA) - General Subjects 2021; 1865(6): 129870 doi: 10.1016/j.bbagen.2021.129870
|
| 14 |
Sergey Koshkin, Anna Danilova, Grigory Raskin, Nikolai Petrov, Olga Bajenova, Stephen J. O’Brien, Alexey Tomilin, Elena Tolkunova. Primary cultures of human colon cancer as a model to study cancer stem cells. Tumor Biology 2016; 37(9): 12833 doi: 10.1007/s13277-016-5214-8
|
| 15 |
Li‐Juan Zhao, Ying‐Ying Li, Yu‐Tong Zhang, Qi‐Qi Fan, Hong‐Mei Ren, Cheng Zhang, Adil Mardinoglu, Wen‐Chao Chen, Jing‐Ru Pang, Dan‐Dan Shen, Jun‐Wei Wang, Long‐Fei Zhao, Jian‐Ying Zhang, Zhen‐Ya Wang, Yi‐Chao Zheng, Hong‐Min Liu. Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness. EMBO reports 2021; 22(8) doi: 10.15252/embr.202050922
|
| 16 |
Zhishuo Zhang, Wenxia Zhao, Yiming Li, Yang Li, Hanzeng Cheng, Liyun Zheng, Xiaoyu Sun, Hao Liu, Rongguang Shao. YOD1 serves as a potential prognostic biomarker for pancreatic cancer. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02616-9
|
| 17 |
Virender Kumar, Goutam Mondal, Paige Slavik, Satyanarayna Rachagani, Surinder K. Batra, Ram I. Mahato. Codelivery of Small Molecule Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer. Molecular Pharmaceutics 2015; 12(4): 1289 doi: 10.1021/mp500847s
|
| 18 |
Divya Singh, Ghanshyam Upadhyay, Rakesh K. Srivastava, Sharmila Shankar. Recent advances in pancreatic cancer: biology, treatment, and prevention. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2015; 1856(1): 13 doi: 10.1016/j.bbcan.2015.04.003
|
| 19 |
Tasuku Matsuoka, Masakazu Yashiro. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies. World Journal of Gastroenterology 2016; 22(2): 776-789 doi: 10.3748/wjg.v22.i2.776
|
| 20 |
Deepanshi Dhar, Gagan Deep, Sushil Kumar, Michael F. Wempe, Komal Raina, Chapla Agarwal, Rajesh Agarwal. Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. Molecular Carcinogenesis 2018; 57(9): 1166 doi: 10.1002/mc.22833
|
| 21 |
Fabio Grizzi, Sirio Fiorino, Dorina Qehajaj, Adele Fornelli, Carlo Russo, Dario de Biase, Michele Masetti, Laura Mastrangelo, Matteo Zanello, Raffaele Lombardi, Andrea Domanico, Esterita Accogli, Andrea Tura, Leonardo Mirandola, Maurizio Chiriva-Internati, Robert S. Bresalier, Elio Jovine, Paolo Leandri, Luca Di Tommaso. Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1817-3
|
| 22 |
Yan-Jia Guo, Jing-Ru Pang, Yu Zhang, Zhong-Rui Li, Xiao-Lin Zi, Hong-Min Liu, Ning Wang, Li-Juan Zhao, Ya Gao, Bo Wang, Piet Herdewijn, Cheng-Yun Jin, Ying Liu, Yi-Chao Zheng. Neddylation-dependent LSD1 destabilization inhibits the stemness and chemoresistance of gastric cancer. International Journal of Biological Macromolecules 2024; 254: 126801 doi: 10.1016/j.ijbiomac.2023.126801
|
| 23 |
Hsing-Yu Wu, Ming-Chen Yang, Li-Yun Ding, Ching S. Chen, Po-Chen Chu. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cells. Cancer Letters 2019; 456: 13 doi: 10.1016/j.canlet.2019.04.026
|
| 24 |
Clifford C. Nwaeburu, Alia Abukiwan, Zhefu Zhao, Ingrid Herr. RETRACTED ARTICLE: Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0589-8
|
| 25 |
Cynthia I Tchio Mantho, Adriana Harbuzariu, Ruben R Gonzalez-Perez. Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer. World Journal of Clinical Oncology 2017; 8(3): 178-189 doi: 10.5306/wjco.v8.i3.178
|
| 26 |
Anna Lyberopoulou, Gerasimos Aravantinos, Efstathios P. Efstathopoulos, Nikolaos Nikiteas, Penelope Bouziotis, Athina Isaakidou, Apostolos Papalois, Evangelos Marinos, Maria Gazouli, Javier S Castresana. Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor Tissue. PLOS ONE 2015; 10(4): e0123902 doi: 10.1371/journal.pone.0123902
|
| 27 |
Jiang Ruibin, Cheng Guoping, Zheng Zhiguo, Ni Maowei, Wan Danying, Feng Jianguo, Gu Linhui. Establishment and Characterization of a Highly Metastatic Ovarian Cancer Cell Line. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3972534
|
| 28 |
Cristiana Tanase, Radu Albulescu, Monica Neagu. Proteomic Approaches for Biomarker Panels in Cancer. Journal of Immunoassay and Immunochemistry 2016; 37(1): 1 doi: 10.1080/15321819.2015.1116009
|
| 29 |
Koji Munakata, Mamoru Uemura, Shinji Tanaka, Kenji Kawai, Tomohiro Kitahara, Masaaki Miyo, Yoshihiro Kano, Shinpei Nishikawa, Takahito Fukusumi, Yusuke Takahashi, Taishi Hata, Junichi Nishimura, Ichiro Takemasa, Tsunekazu Mizushima, Masakazu Ikenaga, Takeshi Kato, Kohei Murata, John M. Carethers, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori. Cancer Stem-like Properties in Colorectal Cancer Cells with Low Proteasome Activity. Clinical Cancer Research 2016; 22(21): 5277 doi: 10.1158/1078-0432.CCR-15-1945
|
| 30 |
Bai-Shun Wan, Ming Cheng, Ling Zhang. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation <i>via</i> activation of AKT and is directly targeted by microRNA-494 in pancreatic cancer. World Journal of Gastroenterology 2019; 25(40): 6063-6076 doi: 10.3748/wjg.v25.i40.6063
|
| 31 |
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Chiara Birtolo, Giorgia Acquaviva, Michela Visani, Adele Fornelli, Michele Masetti, Andrea Tura, Stefano Sbrignadello, Fabio Grizzi, Federica Patrinicola, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Claudia Benini, Luca Di Tommaso, Arrigo Bondi, Francesco Monetti, Elena Siopis, Paolo Emilio Orlandi, Michele Imbriani, Carlo Fabbri, Silvia Giovanelli, Andrea Domanico, Esterita Accogli, Salomone Di Saverio, Daniela Grifoni, Vincenzo Cennamo, Paolo Leandri, Elio Jovine, Dario de Biase. Matricellular proteins and survival in patients with pancreatic cancer: A systematic review. Pancreatology 2018; 18(1): 122 doi: 10.1016/j.pan.2017.11.001
|
| 32 |
Xiaoxiao Liu, Zhang Li, Yuexiang Wang. Advances in Targeted Therapy and Immunotherapy for Pancreatic Cancer. Advanced Biology 2021; 5(3) doi: 10.1002/adbi.201900236
|
| 33 |
Tatsuya Usui, Masashi Sakurai, Shuhei Enjoji, Hideyoshi Kawasaki, Koji Umata, Takashi Ohama, Nobuyuki Fujiwara, Ryotaro Yabe, Shunya Tsuji, Hideyuki Yamawaki, Shoichi Hazama, Hiroko Takenouchi, Masao Nakajima, Ryouichi Tsunedomi, Nobuaki Suzuki, Hiroaki Nagano, Koichi Sato, Dominik Wolf. Establishment of a Novel Model for Anticancer Drug Resistance in Three‐Dimensional Primary Culture of Tumor Microenvironment. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/7053872
|
| 34 |
Garima Kaushik, Parthasarathy Seshacharyulu, Sanchita Rauth, Palanisamy Nallasamy, Satyanarayana Rachagani, Rama Krishna Nimmakayala, Raghupathy Vengoji, Kavita Mallya, Ramakanth Chirravuri-Venkata, Amar B. Singh, Jason M. Foster, Quan P. Ly, Lynette M. Smith, Subodh M. Lele, Mokenge P. Malafa, Maneesh Jain, Moorthy P. Ponnusamy, Surinder K. Batra. Selective inhibition of stemness through EGFR/FOXA2/SOX9 axis reduces pancreatic cancer metastasis. Oncogene 2021; 40(4): 848 doi: 10.1038/s41388-020-01564-w
|
| 35 |
Vlad Herlea, Elena Stoica Mustafa, Andreea Cristina Iorgescu, Nicolae Catalin Pechianu, Dragos Cretoiu, Maria Sajin, Simona Olimpia Dima, Catalin Vasilescu, Cezar Stroescu, Constantin Ungureanu, Traian Dumitrascu, Vladislav Brasoveanu, Minerva Ghinescu, Irinel Popescu, Monica Neagu. A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma. Journal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/6148286
|
| 36 |
Xiong Tian, Jing Zheng, Wanlan Mou, Guoguang Lu, Shuaishuai Chen, Juping Du, Yufen Zheng, Shiyong Chen, Bo Shen, Jun Li, Na Wang. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.939542
|
| 37 |
Ingrid Garajová, Elisa Giovannetti, Sara Caponi, Annette van Zweeden, Godefridus J. Peters. MiRNAs and Their Interference with the Main Molecular Mechanisms Responsible for Drug Resistance in Pancreatic Cancer. Current Pharmacology Reports 2015; 1(4): 223 doi: 10.1007/s40495-014-0008-4
|
| 38 |
Chi‐Cheng Huang, Chien‐Min Lin, Yan‐Jiun Huang, Li Wei, Lei‐Li Ting, Chia‐Chun Kuo, Cheyu Hsu, Jeng‐Fong Chiou, Alexander T. H. Wu, Wei‐Hwa Lee. Garcinol downregulates Notch1 signaling via modulating miR‐200c and suppresses oncogenic properties of PANC‐1 cancer stem‐like cells. Biotechnology and Applied Biochemistry 2017; 64(2): 165 doi: 10.1002/bab.1446
|
| 39 |
Nikhil Tyagi, Saravanakumar Marimuthu, Arun Bhardwaj, Sachin K. Deshmukh, Sanjeev K. Srivastava, Ajay P. Singh, Steven McClellan, James E. Carter, Seema Singh. p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling. Cancer Letters 2016; 370(2): 260 doi: 10.1016/j.canlet.2015.10.028
|